Search Within

Neeta Pandit-Taskar

  1. "2005"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Molecular Imaging and Therapy Service (9)
  2. Radiology, Department of (9)
  3. Department of Medicine (4)
  4. GSK Faculty (3)
  5. Hematologic Malignancies, Division of (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)

More Groups

People
  1. Chaitanya Divgi (7)
  2. Steven Larson (3)
  3. Andrew Zelenetz (2)
  4. Howard Scher (2)
  5. Michael Morris (2)
  6. Ronald Finn (2)

More People

Years
  1. 2005 (9)
Publications
  1. Clinical Cancer Research (2)
  2. Journal of Nuclear Medicine (2)
  3. Annals of Oncology (1)
  4. Blood (1)
  5. Current Urology Reports (1)
  6. European Journal of Nuclear Medicine and Molecular Imaging (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Society of Nuclear Medicine (2)
  3. Springer (2)
  4. American Society of Hematology (1)
  5. C M P Medica LLC * The Oncology Group (1)
  6. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP chemotherapy for mantle cell lymphoma is a safe and highly effective regimen
    Meeting Abstract

    Zelenetz, A.; Donnelly, G.; Pandit-Taskar, N.; Humm, J.; Divgi, C.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Hu3S193, a humanized monoclonal antibody directed against Lewis Y, demonstrates strong targeting to small cell lung cancer (SCLC) in patients
    Meeting Abstract

    Krug, L. M.; Milton, D. T.; Chen, L. C.; Jungbluth, A. A.; Nagel, A.; Finn, R.; Pandit-Taskar, N.; Jones, J.; Divgi, C.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • JNM supplement on molecular radiotherapy - Reply
    Journal Article

    Pandit-Taskar, N.; Larson, S. M.
    Journal of Nuclear Medicine (2005)

    Fulltext@MSK | Save
  • The Sachelarie/Kerr/Ghesani et al article reviewed [Integrated PET-CT: Evidence-based review of oncology indications]
    Journal Article

    Pandit-Taskar, N.; Divgi, C. R.
    Oncology (Norwalk) (2005)

    Fulltext@MSK | Save
  • Oncologic imaging in gynecologic malignancies
    Journal Article

    Pandit-Taskar, N.
    Journal of Nuclear Medicine (2005)

    Fulltext@MSK | Save
  • Targeting osseous metastases: Rationale and development of radio-immunotherapy for prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C.; Larson, S.; Scher, H. I.
    Current Urology Reports (2005)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • PET: Too much of a good thing? Does the plethora of choices impact on patient management?
    Journal Article

    Divgi, C.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2005)

    Fulltext@MSK | Save